These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 39356361)

  • 1. Euphorbia helioscopia L. extract suppresses hepatitis B virus-related hepatocellular carcinoma via alpha serine/threonine-protein kinase and Caspase-3.
    Xiong D; Gong M; Hou Y; Chen H; Gao T; He L
    J Cancer Res Clin Oncol; 2024 Oct; 150(10):442. PubMed ID: 39356361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JS-K, a nitric oxide prodrug, induces DNA damage and apoptosis in HBV-positive hepatocellular carcinoma HepG2.2.15 cell.
    Liu Z; Li G; Gou Y; Xiao D; Luo G; Saavedra JE; Liu J; Wang H
    Biomed Pharmacother; 2017 Aug; 92():989-997. PubMed ID: 28605880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of emodin in treating hepatitis B virus-associated hepatocellular carcinoma: network pharmacology and cell experiments.
    Wang Y; Li S; Ren T; Zhang Y; Li B; Geng X
    Front Cell Infect Microbiol; 2024; 14():1458913. PubMed ID: 39346898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOD1 inhibition enhances sorafenib efficacy in HBV-related hepatocellular carcinoma by modulating PI3K/Akt/mTOR pathway and ROS-mediated cell death.
    Lee J; Kim J; Lee R; Lee E; An HI; Kwon YJ; Jin H; Pack CG; Kim I; Yoon YI; Park GC; Jwa EK; Kwon JH; Namgoong JM; Song GW; Hwang S; Tak E; Lee SG
    J Cell Mol Med; 2024 Jul; 28(14):e18533. PubMed ID: 39034442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AC099850.3 promotes HBV-HCC cell proliferation and invasion through regulating CD276: a novel strategy for sorafenib and immune checkpoint combination therapy.
    He A; Huang Z; Feng Q; Zhang S; Li F; Li D; Lu H; Wang J
    J Transl Med; 2024 Aug; 22(1):809. PubMed ID: 39217342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amygdalin promotes the activity of T cells to suppress the progression of HBV-related hepatocellular carcinoma via the JAK2/STAT3 signaling pathway.
    Wang R; Zhang D; Sun K; Peng J; Zhu W; Yin S; Tang D; Wu Y
    BMC Infect Dis; 2021 Jan; 21(1):56. PubMed ID: 33435880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-1271 functions as a potential tumor suppressor in hepatitis B virus-associated hepatocellular carcinoma through the AMPK signaling pathway by binding to CCNA1.
    Chen Y; Zhao ZX; Huang F; Yuan XW; Deng L; Tang D
    J Cell Physiol; 2019 Apr; 234(4):3555-3569. PubMed ID: 30565670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study on the mechanism of quercetin in Sini Decoction Plus Ginseng Soup to inhibit liver cancer and HBV virus replication through CDK1.
    Hao L; Li S; Chen G; Nie A; Zeng L; Xiao Z; Hu X
    Chem Biol Drug Des; 2024 Jun; 103(6):e14567. PubMed ID: 38858165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase.
    Fei X; Zhang P; Pan Y; Liu Y
    Yonsei Med J; 2020 Jun; 61(6):460-470. PubMed ID: 32469170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artemisia capillaris extract AC68 induces apoptosis of hepatocellular carcinoma by blocking the PI3K/AKT pathway.
    Yan H; Jung KH; Kim J; Rumman M; Oh MS; Hong SS
    Biomed Pharmacother; 2018 Feb; 98():134-141. PubMed ID: 29253760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus PreS1 facilitates hepatocellular carcinoma development by promoting appearance and self-renewal of liver cancer stem cells.
    Liu Z; Dai X; Wang T; Zhang C; Zhang W; Zhang W; Zhang Q; Wu K; Liu F; Liu Y; Wu J
    Cancer Lett; 2017 Aug; 400():149-160. PubMed ID: 28455240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus promotes proliferation and metastasis in male Chinese hepatocellular carcinoma patients through the LEF-1/miR-371a-5p/SRCIN1/pleiotrophin/Slug pathway.
    Bai PS; Hou P; Kong Y
    Exp Cell Res; 2018 Sep; 370(1):174-188. PubMed ID: 29928866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.
    Hong B; Qian Y; Zhang H; Sang YW; Cheng LF; Wang Q; Gao S; Zheng M; Yao HP
    World J Gastroenterol; 2016 May; 22(18):4538-46. PubMed ID: 27182163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scutellaria barbata D.Don and Oldenlandia diffusa (Willd.) Roxb crude extracts inhibit hepatitis-B-virus-associated hepatocellular carcinoma growth through regulating circRNA expression.
    Yang PW; Chen TT; Zhao WX; Liu GW; Feng XJ; Wang SM; Pan YC; Wang Q; Zhang SH
    J Ethnopharmacol; 2021 Jul; 275():114110. PubMed ID: 33864890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Euphorbia factor L2 inhibits TGF-β-induced cell growth and migration of hepatocellular carcinoma through AKT/STAT3.
    Fan L; Zhu H; Tao W; Liu L; Shan X; Zhao M; Sun D
    Phytomedicine; 2019 Sep; 62():152931. PubMed ID: 31085375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoration of miR-193b sensitizes Hepatitis B virus-associated hepatocellular carcinoma to sorafenib.
    Mao K; Zhang J; He C; Xu K; Liu J; Sun J; Wu G; Tan C; Zeng Y; Wang J; Xiao Z
    Cancer Lett; 2014 Oct; 352(2):245-52. PubMed ID: 25034398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of targets of JS-K against HBV-positive human hepatocellular carcinoma HepG2.2.15 cells with iTRAQ proteomics.
    Liu Z; Xu Y; Zhang W; Gao X; Luo G; Song H; Liu J; Wang H
    Sci Rep; 2021 May; 11(1):10381. PubMed ID: 34001947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Da-Chai-Hu-Tang Formula inhibits the progression and metastasis in HepG2 cells through modulation of the PI3K/AKT/STAT3-induced cell cycle arrest and apoptosis.
    Duan ZW; Liu Y; Zhang PP; Hu JY; Mo ZX; Liu WQ; Ma X; Zhou XH; Wang XH; Hu XH; Wei SL
    J Ethnopharmacol; 2024 Sep; 331():118293. PubMed ID: 38705430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation Promotes Expression of Stemness-Related Properties in HBV-Related Hepatocellular Carcinoma.
    Chang TS; Chen CL; Wu YC; Liu JJ; Kuo YC; Lee KF; Lin SY; Lin SE; Tung SY; Kuo LM; Tsai YH; Huang YH
    PLoS One; 2016; 11(2):e0149897. PubMed ID: 26919045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small HBV surface antigen drives regorafenib resistance in HCC via KIAA1429-dependent m6A modification of CCR9.
    Lv Z; Liu L; You J; Zhou P; Su Y; Zhao K; Zhang J; Zhu F
    J Med Virol; 2024 Sep; 96(9):e29894. PubMed ID: 39206838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.